Drug · DIN 02551772
AYVAKYT
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 2, 2024; first marketed December 2, 2024.
- Drug Identification Number (DIN)
- 02551772
- Company (DIN owner)
- Blueprint Medicines CorporationCambridge, Massachusetts, United States
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Avapritinib L01EX18
- Class
- Human
- Record last updated
- May 26, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AVAPRITINIB | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 18, 2024: NOC 34039New Drug Submission (NDS)
Other DINs named AYVAKYT
- DIN 02551764 · Marketed
- DIN 02551780 · Marketed
- DIN 02551799 · Marketed